Abstract
The efficacy of fluorescent optical contrast agents under development for receptor-targeted tumor detection and imaging was assessed in vivo. Tumor targeting of a dye-peptide system is demonstrated and compared to the non-specific retention of the dye alone.
© 2000 Optical Society of America
PDF ArticleMore Like This
Alma R. Morales, Ciceron O. Yanez, Takeo Urakami, Masanobu Komatsu, and Kevin D. Belfield
MW5C.2 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2013
Michael Gurfinkel, Alan B. Thompson, William Ralston, Tamara L. Troy, Jeffery S. Reynolds, Bruce Muggenberger, Kristin Nikula, Ravindra Pandey, Ralf Mayer, Daniel J. Hawrysz, and Eva M. Sevick-Muraca
MD7 Biomedical Optical Spectroscopy and Diagnostics (BIOMED) 2000
Congying Zhang and Yueqing Gu
JT3A.12 Bio-Optics: Design and Application (BODA) 2015